Cardiac lipoma of the right atrial appendage: Multimodality imaging of a rare tumor at an uncommon site Authors: Paisit Kosum, Monravee Tumkosit, Luxica Jarutasnangkul, Poonchavist Chantranuwatana, Apichaya Pakdeepaithun, Padet Tanangterapong, Nonthikorn Theerasuwipakorn Published: 2026 ABSTRACT AbstractCardiac lipomas are rare benign tumors that are often asymptomatic and discovered incidentally. While the right atrium is a recognized location for such tumors, involvement of the right atrial appendage (RAA) has not been previously reported. We describe a 60-year-old woman presenting with acute pulmonary embolism, during which a small, mobile, fat-containing mass in the RAA was incidentally discovered on computed tomography pulmonary angiography. Further characterization by cardiac magnetic resonance imaging confirmed features consistent with a lipoma. Although the lipoma was not directly implicated in the embolic event, which was the cause of the patient’s symptoms, its mobility and location raised concerns for future complications. RAA involvement poses unique diagnostic and management challenges. Its narrow orifice often limits transthoracic echocardiography sensitivity, frequently requiring advanced multimodality imaging for detection. Furthermore, the relatively stagnant blood flow within the appendage, combined with a mobile mass, increases the theoretical risk of blood flow obstruction and secondary thrombus formation. Preoperative detection is critical, as the RAA is a common site for venous cannulation; its involvement requires modified surgical strategies to prevent accidental tumor dislodgement or impaired venous return. A multidisciplinary team recommended surgical resection, which was successfully performed via minimally invasive cardiac surgery. Histopathology confirmed a benign lipoma. This case highlights the diagnostic value of multimodality imaging in evaluating incidental cardiac masses, the importance of individualized risk assessment, and the unique procedural considerations posed by RAA involvement.Keywords: Cardiac lipoma, Cardiac tumor, Multimodality imaging, Right atrial appendage Introduction Cardiac lipomas are rare benign tumors that account for a small percentage of primary cardiac neoplasms [1]. They are typically asymptomatic and discovered incidentally during imaging for unrelated conditions [2]. While lipomas have been reported in various cardiac locations, including the right atrium, left ventricle, and pericardium, involvement of the right atrial appendage (RAA) has not been previously documented [3]. This report presents the first known case of an RAA lipoma, incidentally detected during evaluation for pulmonary embolism. Case presentation A 60-year-old woman presented with progressive exertional dyspnea and a sudden episode of transient loss of consciousness. Her medical history was notable for hypertension, dyslipidemia, and mild hepatic steatosis. She denied any history of chest discomfort, palpitation, or abnormal movement. On physical examination, the only notable findings were tachycardia with a regular pulse and mild hypoxemia with a peripheral oxygen saturation of 92%. Other findings were unremarkable. Electrocardiography (ECG) showed sinus tachycardia without significant ST-T segment changes. Chest radiography revealed cardiomegaly without pulmonary infiltration. Transthoracic echocardiography (TTE) demonstrated normal biventricular size and systolic function without valvular dysfunction, intracardiac mass, or thrombus. CTPA depicted a saddle pulmonary embolism involving the distal pulmonary trunk, both the right and left main pulmonary arteries, extending into their lobar, segmental, and subsegmental branches supplying both upper lobes, the right middle lobe, and both lower lobes (Fig. 1A). The diameter of the pulmonary trunk was within normal limits (2.6 cm), and no pulmonary parenchymal lesions were identified. A 2.3 × 1.3-cm nonenhanced, fat-containing mass (−70 Hounsfield unit) was incidentally detected in the RAA (Figs. 1B and C). This markedly low attenuation value confidently excluded thrombus, which typically exhibits significantly higher density. Cardiac magnetic resonance imaging (CMR) with steady-state free precession (SSFP) cine in axial view demonstrated a 2.1 × 1.2-cm hypermobile, oval-shaped mass with a surrounding chemical shift artifact, located at the orifice of the RAA (Fig. 1D). The minor discrepancy in dimensions compared to CTPA likely reflects the mass's high mobility and inherent differences in the spatial resolution of the imaging modalities. First-pass perfusion imaging and phase-sensitive inversion recovery late gadolinium enhancement (PSIR-LGE) showed no evidence of vascularity (Figs. 1E and F). Additionally, the long inversion time (long TI) sequence showed a complete fat signal, excluding thrombus (Fig. 1G). These imaging features strongly suggested a fat-containing tumor, such as a lipoma, atypical myxoma, or liposarcoma. Based on these findings, the final diagnosis was acute pulmonary embolism involving both pulmonary arteries, along with a fat-containing tumor in the RAA, suspected of cardiac lipoma. A lower-extremity venous Doppler ultrasound did not demonstrate deep vein thrombosis. The laboratory workup for hypercoagulable states was unremarkable. No other provoking factors for pulmonary embolism were identified. Arterial phase CTPA in axial view (A) demonstrated pulmonary embolism (arrowhead) involving the distal pulmonary trunk, right and left main pulmonary, and lobar arteries. Noncontrast (B) and venous phases (C) CTPA in axial view showed a 2.3 × 1.3-cm nonenhanced, fat-containing mass (-70 Hounsfield unit) in the RAA (arrow). Cine CMR with SSFP sequence in axial view (D) revealed a 2.1 × 1.2-cm hypermobile, oval-shaped mass with surrounding chemical shift artifact, located at the orifice of the RAA (arrow). CMR with first-pass perfusion imaging (E) and PSIR-LGE (F) demonstrated no evidence of vascularity (arrow). CMR with the long inversion time sequence in axial view (G) showed a complete fat signal (arrow). CMR, Cardiac magnetic resonance imaging; CTPA, computed tomography pulmonary angiography; LA, left atrium; LV, left ventricle; MPA, main pulmonary artery; PSIR-LGE, phase-sensitive inversion recovery late gadolinium enhancement; RA, right atrium; RAA, right atrial appendage; RV, right ventricle; SSFP, Steady-State Free Precession. Apixaban was prescribed for the management of acute pulmonary embolism. Although the RAA mass was likely incidental, a multidisciplinary team, including cardiologists and cardiothoracic surgeons, recommended elective surgical resection to obtain a definitive histopathological diagnosis and to eliminate any theoretical embolic risk associated with the mobile intracardiac lesion in a confined location like the RAA. To minimize perioperative risk, the procedure was delayed for three months to allow for stabilization and treatment of the acute embolic event. A follow-up CTPA performed three months after the initial presentation demonstrated complete resolution of pulmonary embolism. Following this resolution, the patient provided informed consent and underwent minimally invasive cardiac surgery (MICS) for complete resection of the mass. A complete surgical resection of the mass was successful. Gross pathological examination revealed a 2.3 × 2.3 × 1.5-cm yellow, encapsulated mass (Figs. 2A and B). Microscopic analysis demonstrated a smooth-surfaced, polypoid lesion composed predominantly of mature adipocytes interspersed with entrapped cardiac myocytes. No lipoblasts or atypical cells were identified (Figs. 2C and D). Histopathological evaluation confirmed the diagnosis of cardiac lipoma. Gross pathological examination (A and B) revealed a 2.3 × 2.3 × 1.5-cm yellow, encapsulated mass. Histological examination (C and D) demonstrated mature adipocytes interspersed with entrapped cardiac myocytes with no lipoblasts or atypical cells. The postoperative period was uneventful. At follow-up, dyspnea was gradually resolved without recurrent syncopal episodes. CTPA at 6 months demonstrated complete resolution of pulmonary embolism and no recurrence of intracardiac mass. Discussion The incidence of primary cardiac tumors at autopsy ranges from 0.2% to 0.4%, with cardiac lipomas accounting for approximately 8.4% of these cases [1]. Cardiac lipomas most commonly arise from the subendocardium (50%), followed by the subpericardium (25%) and myocardium (25%) [3]. The distribution of cardiac lipomas is variable, with the most reported sites being the right atrium, left ventricle, and pericardium. Less frequently, lipomas may be found in the right ventricle, left atrium, cardiac valves, or embedded within the myocardium. To the best of our knowledge, this is the first documented case of a lipoma located in the RAA. Most cardiac lipomas are asymptomatic, with symptoms occurring only in a minority of cases, depending on tumor size and location [2]. When symptoms are present, they may include dyspnea (49.7%), palpitations (24.5%), chest pain (19.7%), fatigue (13.6%), and syncopal symptoms (10.9%). Embolic phenomena, including peripheral or pulmonary embolism, are rare but recognized complications [4]. In the present case, although a small lipoma was identified in the RAA, the patient’s clinical presentation of dyspnea and syncope was caused by the saddle pulmonary embolism. No imaging or pathological evidence linked the mass to the embolic event, and the lipoma was therefore considered an incidental finding. TTE remains the first-line imaging modality for evaluating cardiac masses due to its accessibility, real-time capability, and absence of ionizing radiation. Cardiac lipomas typically appear as well-defined, homogeneously hyperechoic masses [5]. However, TTE has limited sensitivity in detecting small or atypically located lesions, particularly within the atrial appendage, due to its narrow orifice and variable orientation relative to standard imaging windows. In this case, the RAA lipoma was not visualized on initial TTE. To improve diagnostic accuracy, additional imaging modalities such as CMR, cardiac computed tomography (CT), or transesophageal echocardiography are valuable for tissue characterization and localization of masses in anatomically challenging regions. Both cardiac CT and CMR offer excellent diagnostic performance in identifying mature adipose tissue. CT typically reveals non-enhancing, encapsulated masses with homogeneous hypodensity (Hounsfield units < −50), occasionally interspersed with linear septa [5]. The CMR diagnosis is confirmed when a mass shows a signal profile identical to subcutaneous fat across all sequences, including complete suppression on fat-saturated imaging and a total lack of contrast enhancement. The black boundary appearance on SSFP cine sequences, a chemical shift artifact, is a pathognomonic sign for identifying the interface between fat and water-based tissues [6]. Emerging tissue mapping techniques can further provide quantitative confirmation. Distinguishing benign cardiac lipomas from malignant liposarcomas remains a diagnostic challenge. Well-differentiated liposarcomas may mimic lipomas on imaging. Suspicion for malignancy increases when nonadipose components, irregular thickened septa, or nodular areas are present within the lesion [3]. In such cases, adjunctive modalities such as positron emission tomography and histopathological examination may be needed for differentiation. The use of CMR in this case was not part of routine pulmonary embolism evaluation but was prompted by the incidental discovery of a mobile, fat-containing intracardiac mass in the RAA on CTPA. Advanced tissue characterization was necessary to differentiate benign from malignant pathology and to inform surgical planning. While CMR is not typically indicated in pulmonary embolism workup, it may be valuable in selected cases with atypical imaging findings or when incidental cardiac lesions are identified. To date, there is no consensus on whether asymptomatic cardiac lipomas should be surgically removed to prevent embolism. In this case, surgical resection was favored due to the lesion’s mobility, its location within the RAA, and the absence of an alternative embolic source. Although lipomas are histologically benign and rarely embolize, mobile lesions in confined anatomical regions like the RAA may pose theoretical risks for blood flow obstruction and thrombus formation within the appendage. Surgical decisions should be individualized based on imaging findings, diagnostic certainty, and clinical context. Factors supporting surgical intervention may include mobility, location in high-risk or narrow regions (eg, atrial appendage), uncertain diagnosis, increasing size, embolic history, or obstructive symptoms such as arrhythmia. From a procedural standpoint, the RAA is frequently used for venous cannulation or manipulated during right atrial exposure. Preoperative recognition of lipoma in this region enables surgical teams to modify cannulation strategies, avoid tumor dislodgement, and prevent impaired venous return. MICS has emerged as a viable and effective treatment option, offering favorable recovery profiles. Although rare, recurrence of cardiac lipoma following complete excision has been reported; therefore, postoperative surveillance with serial imaging is advisable to monitor for recurrence or growth of residual tumor [7]. In conclusion, the RAA location presents unique challenges that differentiate it from other atrial sites. Diagnostically, its complex structures and variable orientation frequently render it a 'blind spot' on standard TTE, necessitating multimodality imaging to identify and characterize masses accurately. Physiologically, the narrow RAA orifice and stagnant blood flow mean that a mobile mass significantly heightens the theoretical risk of flow obstruction or secondary thrombosis. From a management perspective, preoperative recognition is mandatory because the RAA is a primary site for venous cannulation. Failure to identify a mass here preoperatively could lead to accidental tumor dislodgement or impaired venous return during surgery. Therefore, when encountering an RAA lesion on CT, radiologists should not merely document it as an incidental finding but should explicitly describe anatomical correlations and potential complications, such as blood flow obstruction or associated thrombus. Furthermore, CMR should be suggested to definitively characterize the tissue and assess tumor mobility, which are critical for guiding surgical decision-making. Authors' contributions PK drafted the manuscript. PK, LJ, and AP were responsible for patient care and data collection. PK, MT, PC, and NT analyzed the data from investigations, including blood tests, electrocardiography, echocardiography, computed tomography, cardiac magnetic resonance imaging, and histopathology. PK, LJ, AP, PT, and NT created all the figures. PT and NT revised the manuscript. All authors provided comments on the report at various stages of development. All authors read and approved the final manuscript. Ethics approval Ethics committee approval was waived. Availability of data and materials The data for this case report is located at King Chulalongkorn Memorial Hospital, Bangkok, Thailand. Patient consent Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Footnotes Competing Interests: The authors have declared that no competing interests exist. Acknowledgments: The authors acknowledge the support for article processing from the Cardiac Center, King Chulalongkorn Memorial Hospital. References Associated Data Data Availability Statement The data for this case report is located at King Chulalongkorn Memorial Hospital, Bangkok, Thailand.